- Home
- OXSQ vs INMB Comparison
OXSQ vs INMB Comparison
Compare OXSQ & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- INMB
- Stock Information
- Founded
- OXSQ 2003
- INMB 2015
- Country
- OXSQ United States
- INMB United States
- Employees
- OXSQ N/A
- INMB N/A
- Industry
- OXSQ Blank Checks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- OXSQ Finance
- INMB Health Care
- Exchange
- OXSQ Nasdaq
- INMB Nasdaq
- Market Cap
- OXSQ 164.9M
- INMB 176.5M
- IPO Year
- OXSQ N/A
- INMB 2019
- Fundamental
- Price
- OXSQ $2.21
- INMB $6.38
- Analyst Decision
- OXSQ
- INMB Strong Buy
- Analyst Count
- OXSQ 0
- INMB 3
- Target Price
- OXSQ N/A
- INMB $24.33
- AVG Volume (30 Days)
- OXSQ 567.4K
- INMB 627.1K
- Earning Date
- OXSQ 08-12-2025
- INMB 07-31-2025
- Dividend Yield
- OXSQ 19.05%
- INMB N/A
- EPS Growth
- OXSQ N/A
- INMB N/A
- EPS
- OXSQ N/A
- INMB N/A
- Revenue
- OXSQ $42,166,831.00
- INMB $50,000.00
- Revenue This Year
- OXSQ N/A
- INMB $82.14
- Revenue Next Year
- OXSQ N/A
- INMB $28,750.98
- P/E Ratio
- OXSQ N/A
- INMB N/A
- Revenue Growth
- OXSQ N/A
- INMB N/A
- 52 Week Low
- OXSQ $2.19
- INMB $4.32
- 52 Week High
- OXSQ $3.10
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- OXSQ 22.78
- INMB 37.45
- Support Level
- OXSQ $2.26
- INMB $6.68
- Resistance Level
- OXSQ $2.33
- INMB $8.05
- Average True Range (ATR)
- OXSQ 0.03
- INMB 0.62
- MACD
- OXSQ -0.00
- INMB -0.10
- Stochastic Oscillator
- OXSQ 13.33
- INMB 10.31
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.